Table 4 The disease progress at the 5-year follow-up, China, 2009–2014
Initial diagnosis | Person-years | Follow-up diagnosis | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
HBsAg sero-clearance | Carriers | CHBa | LCb | HCCC | |||||||
n | Annual rate (%) | n | Annual rate (%) | n | Annual rate (%) | n | Annual rate (%) | n | Annual rate (%) | ||
Carriers | 821 | 11 | 1.3 | 185 | 22.5 | 56 | 6.8 | 0 | – | 0 | – |
CHB | 391 | 1 | 0.3 | 0 | – | 108 | – | 2 | 0.5 | 0 | – |
LC | 29 | 0 | – | 0 | – | 0 | – | 5 | 17.2 | 2 | 6.9 |
Total | 1212 | 12 | 1.0 | 185 | 15.3 | 164 | 4.6 | 7 | 0.6 | 2 | 0.2 |